Remove Examples Remove Finance Remove Pharmaceuticals Remove System
article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

A star example is Google, which raised a mere $40 million in private funding before its IPO at a $23 billion valuation. Examples like Amyris, Solazyme, Gevo, and KiOR have opened the door for other companies to file. Even if most of their investments fail, a few spectacular successes can "make the fund" for a VC.

Energy 10
article thumbnail

Health Care Is an Investment, and the U.S. Should Start Treating It Like One

Harvard Business Review

health care system woefully underperform relative to those made in health care in other countries. To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. Examples of significant investments in low-value care services abound in the U.S. Yet, investments in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. For academics, publishing and obtaining grants are key to promotion and career advancement.

article thumbnail

Should Companies Retain "Strategic" Cash?

Harvard Business Review

This raises the question of whether retaining strategic cash makes economic sense and should be viewed as a legitimate corporate finance tool in today's environment. As long as the CFO can stipulate that the company does not intend to repatriate the cash, it avoids the incremental tax that will be levied due to the territorial system of U.S.

Company 13
article thumbnail

Using Games to Get a Handle on Bank Risk

Harvard Business Review

A better understanding of the drivers of behavior is needed for both banks and consumers to understand risk, and for the financial system to provide timely and targeted interventions. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects.

Banking 10
article thumbnail

Deep questions: What diving teaches us about uncertainty and risk

Chartered Management Institute

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. As an example of the complications ahead, let’s look at taxes. Carmakers have started using 3D technology to produce parts.